Clinical Trials Logo

Clinical Trial Summary

Intestinal Celiac Disease (CD)-antibodies have been described as the best marker to reveal progression toward villous atrophy and could become the diagnostic marker to make prompt diagnosis in the wide clinical spectrum of CD reducing the delay in diagnosis and treatment. The introduction of either anti-endomysial antibodies (EMA) assay or rapid anti-Transglutaminase 2 (TG2) test on supernatant of mechanically lysed biopsy samples in the clinical practice would improve the diagnosis of CD, especially in clinically challenging scenarios. The availability of an accurate test for identifying intestinal CD-antibodies that do not need the culture of intestinal biopsy is less expensive, less time consuming and easier to perform would facilitate the implementation of such technology outside research laboratories, and enable the diagnosis of CD at the end of Gastrointestinal Endoscopy (GIE).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05786183
Study type Observational
Source IRCCS Burlo Garofolo
Contact Luigina De Leo
Phone +39.040.3785.472
Email luigina.deleo@burlo.trieste.it
Status Recruiting
Phase
Start date February 15, 2020
Completion date March 15, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05530070 - Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies N/A
Completed NCT04604795 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole Phase 1
Completed NCT02965209 - European Novel Motorized Spiral Endoscopy Trial N/A
Completed NCT03543540 - Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease Phase 1
Completed NCT02675283 - Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting N/A
Completed NCT03644602 - Low FODMAPs Diet in Gastrointestinal Disorders N/A
Completed NCT02551289 - MAgnetic Resonance Imaging in COeliac Disease
Active, not recruiting NCT02442219 - A Blood Based Diagnostic Test for Coeliac Disease
Recruiting NCT06001177 - A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease Phase 2
Completed NCT00879749 - Safety Study of Nexvax2 in Subjects With Coeliac Disease Phase 1